Trials / Conditions / Erythematotelangiectatic Rosacea

Erythematotelangiectatic Rosacea

13 registered clinical trials studyying Erythematotelangiectatic Rosacea — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy NCT07343635	The Fourth Affiliated Hospital of Zhejiang University School of Medicine	N/A
Completed	Intradermal BoNT-A Treatment in Erythematotelangiectatic Rosacea NCT06331533	Istanbul Training and Research Hospital	Phase 4
Unknown	Pulsed Dye Laser and Intense Pulsed Light Configured With Different Wavelength Bands in Improving Erythematote NCT05360251	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Terminated	Evaluation of the New Laser PHOTOLASE PLV-585nm for the Treatment of Rosacea NCT03708263	University Hospital, Lille	N/A
Completed	Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride (HCL) 1% Cream for Erythematotelangiectatic Rosacea NCT04153188	Candela Corporation	Phase 4
Completed	A Therapeutic Equivalence Study of Two Metronidazole Gel 1% Topical Treatments of Rosacea NCT02393937	bioRASI, LLC	Phase 3
Completed	Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea NCT02268474	Cutera Inc.	N/A
Completed	Ultherapy® for the Treatment of Erythematotelangiectatic Rosacea NCT02144181	Ulthera, Inc	N/A
Completed	Study to Evaluate the Efficacy and Safety of PAC-14028 Cream in Rosacea Patients NCT02052999	Amorepacific Corporation	Phase 2
Completed	Feasibility Study: Ulthera System for the Treatment of Rosacea NCT01756027	Ulthera, Inc	N/A
Completed	Open Label Pilot Study of Apremilast in Treatment of Rosacea NCT01045551	Julian M. Mackay-Wiggan	Phase 2
Completed	Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea NCT00989014	Galderma R&D	Phase 2
Completed	Combination Therapy for the Treatment of Rosacea NCT00945373	Ellen Marmur	Phase 1